Company / Income Tax
Idexx Laboratories Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$264.7M
FY2025
5-year range
$157.8M / $264.7M
FY2021-FY2025
Trend
+19.3%
vs FY2024
Sector context
#21 of 156
Health Care
What the data says
Idexx Laboratories's income tax of $265M is higher than 87% of companies in the Health Care sector (FY2025). Income Tax has increased for 5 consecutive years, from $80M in FY2020 to $265M in FY2025.
Based on SEC 10-K filings.
$265M in FY2025 with a 5-year CAGR of +27.1%. Top quartile in the Health Care sector.
Increased from $216M to $265M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +13.5%
- 5-Year CAGR
- +27.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 156This company $264.7M Sector average $142.5M
▼
+85.8% above sector average
Key checks
Key Insights
- Idexx Laboratories's income tax has grown for 5 consecutive years.
- 5-year CAGR of +27.1%, indicating consistent growth.
- In FY2025, income tax increased 19.3% year-over-year.
- Ranks #21 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $264.7M | +19.3% |
| FY2024 | $222.0M | +2.7% |
| FY2023 | $216.1M | +19.5% |
| FY2022 | $180.9M | +14.6% |
| FY2021 | $157.8M | +97.6% |
| FY2020 | $79.9M | -15.4% |
| FY2019 | $94.4M | +17.0% |
| FY2018 | $80.7M | -31.5% |
| FY2017 | $117.8M | +18.0% |
| FY2016 | $99.8M | +23.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026